135 related articles for article (PubMed ID: 20734840)
21. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
Nikodemski T
Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
[TBL] [Abstract][Full Text] [Related]
22. Doripenem: position in clinical practice.
Dedhia HV; McKnight R
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
[TBL] [Abstract][Full Text] [Related]
23. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997-2002).
Turner PJ
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):281-9. PubMed ID: 15808320
[TBL] [Abstract][Full Text] [Related]
24. In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
Jones RN; Bell JM; Sader HS; Turnidge JD; Stilwell MG
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):434-9. PubMed ID: 19302927
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
Lee H; Ko KS; Song JH; Peck KR
Microb Drug Resist; 2011 Mar; 17(1):37-45. PubMed ID: 20950191
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran.
Hadadi A; Rasoulinejad M; Maleki Z; Yonesian M; Shirani A; Kourorian Z
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):301-5. PubMed ID: 18036759
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
28. Epidemiologic study of nosocomial bacterial infection of pediatric patients at BMA Medical College and Vajira Hospital.
Tantracheewathorn T; Vititpatarapak N; Phumisantiphong U
J Med Assoc Thai; 2007 Feb; 90(2):258-65. PubMed ID: 17375629
[TBL] [Abstract][Full Text] [Related]
29. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Streit JM; Jones RN; Sader HS; Fritsche TR
Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
Korten V; Ulusoy S; Zarakolu P; Mete B;
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
[TBL] [Abstract][Full Text] [Related]
31. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
32. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
33. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
34. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.
Sader HS; Jones RN
Int J Antimicrob Agents; 2005 Feb; 25(2):95-109. PubMed ID: 15664479
[TBL] [Abstract][Full Text] [Related]
36. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
Saghir S; Faiz M; Saleem M; Younus A; Aziz H
Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
[TBL] [Abstract][Full Text] [Related]
37. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
39. Frequency of Gram-negative bacterial pathogens in bloodstream infections and their resistance to antibiotics in the Czech Republic.
Cermák P; Kolár M; Látal T
Int J Antimicrob Agents; 2004 Apr; 23(4):401-4. PubMed ID: 15081092
[TBL] [Abstract][Full Text] [Related]
40. [Non-fermenting Gram-negative bacilli: distribution in clinical specimens and antimicrobial susceptibility].
Merino LA; Ronconi MC; Marín M; Hreñuk GE; Pato AM
Rev Latinoam Microbiol; 1999; 41(4):279-84. PubMed ID: 10932769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]